ST6GALNAC1 and lung adenocarcinoma: Several studies have indicated enhanced expression of ST6GALNAC1 in several cancer tissues, including lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), and clear-cell renal cell carcinoma (ccRCC) samples [84,85].